Report of Foreign Issuer (6-k)
September 13 2017 - 4:32PM
Edgar (US Regulatory)
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
Pursuant to Rule 13a-16 or 15d-16 of the
Securities Exchange Act of 1934
For the month of September 2017
Commission File Number: 001-36581
Vascular
Biogenics Ltd.
(Translation of registrants name into English)
6 Jonathan Netanyahu St.,
Or Yehuda
Israel 60376
(Address of principal executive offices)
Indicate by check mark whether
the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form
20-F ☒ Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Yes ☐ No
☒
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Yes ☐ No
☒
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to
the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ☐ No
☒
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule
12g3-2(b): 82-
EXPLANATORY NOTE
On September 13, 2017, Vascular Biogenics Ltd. (the Company) announced its annual general meeting of shareholders (the Meeting)
and made available to its shareholders certain other materials in connection with such meeting. Furnished herewith as Exhibits 99.1 and 99.2, respectively, are the following documents relating to the Meeting:
1.
|
Notice of the 2017 Annual General Meeting of Shareholders to be Held on November 15, 2017 and Proxy Statement.
|
2.
|
Proxy card for use in connection with the Companys Meeting.
|
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
VASCULAR BIOGENICS LTD.
|
|
|
|
|
Date: September 13, 2017
|
|
|
|
By:
|
|
/s/ Dror Harats
|
|
|
|
|
Name:
|
|
Dror Harats
|
|
|
|
|
Title:
|
|
Chief Executive Officer
|
3
EXHIBIT INDEX
The following exhibits are furnished as part of this Form 6-K:
|
|
|
Exhibit
|
|
|
|
|
99.1
|
|
Notice of Annual General Meeting of Shareholders to be held on November 15, 2017 and Proxy Statement.
|
|
|
99.2
|
|
Proxy card for use in connection with the Companys Meeting.
|
4
Vascular Biogenics (NASDAQ:VBLT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Vascular Biogenics (NASDAQ:VBLT)
Historical Stock Chart
From Sep 2023 to Sep 2024